Orthopedic Devices - North America

  • North America
  • The Orthopedic Devices market market in North America is anticipated to witness a significant growth in revenue, projected to reach US$17.81bn by 2024.
  • This market is expected to exhibit a steady compound annual growth rate (CAGR 2024-2029) of 3.62%, leading to a market volume of US$21.28bn by 2029.
  • In terms of global comparison, the United States will play a pivotal role in generating the majority of revenue within this market, with an estimated revenue of US$16,020.00m in 2024.
  • The United States is experiencing a growing demand for advanced orthopedic devices due to the aging population and high prevalence of chronic conditions.

Key regions: France, Netherlands, Europe, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Orthopedic Devices market in North America is experiencing significant growth due to several factors. Customer preferences for advanced technology and innovative products, along with an aging population and increasing prevalence of orthopedic conditions, are driving the demand for orthopedic devices in the region. Additionally, local special circumstances such as the availability of advanced healthcare infrastructure and favorable reimbursement policies are contributing to the market's development. Customer preferences in North America are shifting towards orthopedic devices that offer advanced technology and innovative features. Patients are increasingly seeking devices that provide better functionality, durability, and comfort. This demand for advanced technology is driving manufacturers to develop and introduce new products that meet these customer preferences. Additionally, patients are becoming more aware of the benefits of minimally invasive surgeries, leading to an increased demand for orthopedic devices that support these procedures. Trends in the market indicate a growing demand for joint replacement devices, particularly for knee and hip replacements. This can be attributed to the aging population in North America, as older individuals are more prone to orthopedic conditions such as osteoarthritis. The increasing prevalence of obesity is also contributing to the demand for joint replacement devices, as excess weight can put strain on the joints. Furthermore, advancements in implant materials and surgical techniques are making joint replacement procedures more accessible and effective, further driving the market growth. Local special circumstances in North America, such as the availability of advanced healthcare infrastructure and favorable reimbursement policies, are supporting the development of the orthopedic devices market. The region has a well-established healthcare system with advanced hospitals and clinics that provide high-quality orthopedic care. This enables patients to access the latest orthopedic devices and treatments. Additionally, favorable reimbursement policies in countries like the United States ensure that patients have access to affordable orthopedic devices, further driving the market growth. Underlying macroeconomic factors also contribute to the development of the orthopedic devices market in North America. The region has a strong economy and high disposable income levels, allowing individuals to afford expensive orthopedic procedures and devices. Additionally, advancements in healthcare technology and research are driving innovation in the orthopedic devices market, leading to the development of new and improved products. In conclusion, the Orthopedic Devices market in North America is experiencing significant growth due to customer preferences for advanced technology and innovative products, an aging population, and increasing prevalence of orthopedic conditions. Local special circumstances such as advanced healthcare infrastructure and favorable reimbursement policies, along with underlying macroeconomic factors, are also contributing to the market's development.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)